| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Patel Naimish is a Chief Medical Officer at CRISPR Therapeutics AG. Recent SEC Form 4 filings include 0 buys and 3 sells.
Estimated insider holdings value: $1.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 29, 2026 | CRSP Crispr Therapeutics AG | Chief Medical Officer | Sale+OE | 3,786 | $55.62 | $210,577.32 | -16.4% | - | - | |
| Mar 16, 2026 | CRSP Crispr Therapeutics AG | Chief Medical Officer | Sale+OE | 3,150 | $48.26 | $152,019.00 | -19.3% | +2.9% | - | |
| May 29, 2025 | CRSP Crispr Therapeutics AG | Chief Medical Officer | Sale+OE | 3,932 | $35.94 | $141,316.08 | -39.3% | +45.5% | - |